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Cystic fibrosis or not? Familial occurrence 
of a rare mutation in the CFTR gene 
Abstract
Cystic fibrosis is a monogenic disease caused by a mutation in the CFTR gene. The classic presentation of the disease includes 
chronic bronchopulmonary symptoms. However, abnormalities in this gene may also be manifested by other phenotypes, 
so-called CFTR-related disorders. This is a group of entities including disseminated bronchiectasis, congenital bilateral absence of 
vas deferens, and chronic pancreatitis. In this article, we present a family with a rare F1052V mutation and a polymorphic variant 
of IVS-5T+11TG. No classical form of the disease was observed in any of the persons affected by the above changes. Results of 
special investigations are also not typical, which hinders unequivocal diagnosis.
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Introduction
Cystic fibrosis (CF) is the most common 
monogenic disease with autosomal recessive 
inheritance in the Caucasian population. Cystic 
fibrosis occurs with a frequency of about 1:4000–
5000, asymptomatic carriers represent 2–5% of 
the white people’s population. It is caused by 
a mutation in the CFTR gene encoding a cAMP-de-
pendent chloride channel. Over 2000 mutations 
in this gene have been described so far [1, 2]. 
The CFTR protein is a regulator of ion and water 
transport in epithelia. Disruption of this function 
leads to increased viscosity and density of mucus, 
and consequently, to impairment of organ func-
tion. The most frequent clinical form of cystic 
fibrosis is a chronic bronchopulmonary disease. 
Exocrine pancreas failure and male infertility 
also commonly occur [3]. The CFTR gene is also 
associated with other phenotypes that do not meet 
the cystic fibrosis diagnostic criteria. These are 
so-called CFTR-related disorders, which include, 
among others, disseminated bronchiectasis, con-
genital bilateral absence of vas deferens (CBAVD), 
or chronic pancreatitis [1, 4]. In this paper, we 
present the case of a family with a rare mutation 
in the CFTR gene. The aim of the study is to draw 
attention to diagnostic difficulties that a clinician 
may meet in such a situation.
Case report
We report a case of a 10-year-old boy who had 
an abnormal level of immunoreactive trypsinogen 
on screening, presenting early childhood symptoms 
that suggested cystic fibrosis, primarily frequent 
respiratory infections. However, the chloride level 
in sweat was normal. Extended genetic diagnos-
tics revealed mutations in the CFTR gene in the 
proband’s family. The following genotypes were 
found: F1052V/IVS8-5T+11TG in the proband, 
IVS8-5T+11TG/- in the proband’s mother and 
stepbrother, and F1052V/F1052V at the proband’s 
father. The family tree is presented in Figure 1.
Due to the respiratory tract infections, peri-
odically found atopic skin changes, increased IgE 
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level and eosinophils in the peripheral blood, the 
boy was suspected of bronchial asthma. A feature 
that has also drawn attention in the physical ex-
amination was obesity. In addition, the patient re-
mains under the care of a cardiological outpatient 
clinic due to the tricuspid valve incompetence, 
pulmonary valve incompetence, and suspicion 
of hypertension. 
A 34-year-old father of the proband has pre-
sented symptoms suggesting bronchial asthma, 
he has suffered from recurrent sinusitis, he has 
undergone nasal polyp resection, but he has never 
been diagnosed with cystic fibrosis. There was 
a case of infant death due to lung disease in the 
patient’s father’s family (II:7 in Figure 1). The 
father’s sister has been detected as a carrier of the 
F1052V mutation (II:11 in Figure 1). 
No clinical symptoms suggesting chronic 
respiratory disease were observed in the mother 
or stepbrother of the proband. Genetic testing of 
the mother’s parents did not reveal a mutation 
in the CFTR gene, therefore, the IVS8-5T+11TG 
variant has de novo nature.
Discussion
The p.F1052V change is a rare mutation 
found in cystic fibrosis. It was first described 
by Mercier et al. in 1993 [5]. The substitution of 
phenylalanine to valine in the second transmem-
brane span of the CFTR protein is likely to affect 
the hydrophobic structure of this domain. Cases 
of patients with heterozygous mutation F1052V 
who had normal chloride levels in sweat were 
described in the medical literature [6, 7]. Our 
observation corresponds with the above reports, 
despite the presence of the discussed mutation 
in one allele, the proband has normal results of 
a sweat chloride test. 
The proband’s father has a homozygous 
p.F1052V mutation. This substitution may have 
varying clinical consequences [8]. According to 
the Consensus Guidelines from the Cystic Fibro-
sis Foundation, the presence of undefined CFTR 
genotype or a known mutation of varying clinical 
consequences indicates the need for CFTR phys-
iologic testing, such as nasal potential difference 
(NPD). However, the basis of the diagnostic pro-
cess is the clinical presentation of CF (signs and 
symptoms) [9]. The proband’s father presented 
symptoms from the respiratory tract, but they 
did not include the classic CF picture. Further 
diagnostics would be recommended — the chlo-
ride level in sweat, NPD and functional tests of 
the respiratory system. However, the boy’s father 
denies the possibility of the disease and does not 
want to undergo examinations.
The presence of a rare F1052V homozygous 
mutation is striking. This may be due to the ran-
dom occurrence of the same de novo mutation in 
parents. Another situation is uniparental disomy 
(UDP), which occurs very rarely, but is possible. 
In the next stage, the consanguinity of the parents 
should be considered. No information was obtained 
about the common ancestor of the parents of the 
proband’s father, but it is known that they came 
from two neighboring localities. Therefore, the 
hypothesis of consanguinity seems most likely in 
this case. Only 1 patient with homozygous F1052V 
mutation has been registered in the cftr2.org 
database so far [8].
The presence of the IVS8-5T variant in intron 
8 in combination with the increased number of 
TG repeats leads to the elimination of exon 9 and 
the decrease in the production of mRNA for the 
CFTR protein [10, 11]. This is not associated with 
the classic presentation of cystic fibrosis, but it 
can lead to CFTR-related disorder. The IVS8- 
Figure 1. The family tree. The presence of the F1052V mutation is marked in gray and the presence of the variant IVS8-5T+11TG in the hatched box
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-5T+11TG variant occurring in the proband’s 
family has been reported in patients with congen-
ital bilateral absence of vas deferens [12]. Due to 
the heterozygosity of this variant in the proband 
and his stepbrother, it seems right to observe 
boys for infertility. According to the European 
diagnostic recommendations for CFTR-related 
disorders in a patient with male infertility with 
CBAVD, the presence of one CF-specific mutation 
and the IVS8-5T variant is sufficient to diagnose 
CFTR-related disorder [13]. If the proband devel-
ops infertility in the future, it will probably be 
possible to make a final diagnosis.
In the presented case, the familial occurrence 
of a rare mutation and a polymorphic variant in 
the CFTR gene, an equivocal clinical picture, as 
well as normal chloride levels in sweat make the 
diagnosing difficult. In contrast, the proband 
himself, despite the presence of respiratory 
symptoms, has only one mutated CFTR gene 
allele. In the second one, there is a polymorphic 
variant that is associated with CFTR-related 
disorders. The patient remains under the care of 
a pulmonological outpatient clinic to control for 
clinical signs of cystic fibrosis. Due to the above 
features, the final diagnosis can probably be made 
after the exclusion or confirmation of male infer-
tility associated with congenital bilateral absence 
of vas deferens. We believe that it is important 
to control regularly patients with known CFTR 
genotype, even if they do not present classic 
clinical symptoms because CF can vary over 
time. Also, we would like to point out the need 
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